Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

Who Is a Good Candidate for Ibogaine? with Fernando Rivas, MD

In this episode of the Psychedelic Medicine Podcast, Fernando Rivas, MD, joins to unpack the safety and screening considerations for ibogaine therapy. Dr. Rivas is an emergency physician with over 15 years of clinical experience. As Chief Medical Officer of Transcend Clinic, he has led the development of innovative treatment protocols in addiction medicine and the clinical application of ibogaine.

In this conversation, Dr. Rivas discusses who may be a good candidate for ibogaine therapy and the clinical considerations involved in determining its safety. He explains that ibogaine has the strongest current support for interrupting substance use disorders and addressing TBI and PTSD, while potential applications in other areas remain emerging and require further research. Throughout the conversation, Dr. Rivas emphasizes the importance of distinguishing absolute from relative contraindications and of carefully screening patients for psychiatric risks, cardiac conditions, and medication interactions. He also discusses medically supported detox protocols, the importance of evaluating treatment through an individualized risk-benefit framework, and how lower-dose or non-psychedelic approaches may eventually broaden access to ibogaine's potential neuroplastic effects.

In this episode, you'll hear:

  • What conditions ibogaine has been most studied for and where its potential applications may be expanding
  • The psychiatric and physical conditions that may make someone an unsuitable candidate for ibogaine treatment
  • How patients with active opioid or alcohol use may be medically supported and stabilized before treatment
  • Why relative contraindications should be evaluated through an individualized risk-benefit analysis
  • How ibogaine's typical psychedelic experience may be shorter than its reputation suggests
  • Why the immediate improvements some patients experience should be understood within the broader context of neuroplasticity and long-term integration

Quotes:

"Ibogaine is the most robust of the [psycho]plastogens in terms of the window of time that it is able to open [for increased neuroplasticity]—at least as per preclinical research. So the potential is tremendous." [3:22]

"Cardiovascular health is the most important [safety consideration for ibogaine therapy]. If you have a big hypertrophic heart and a large dilated heart, the risks are greater. If you have rhythm disturbances, the risks are greater and sometimes unacceptable." [11:08]

"The chances [of an adverse cardiac event] are mitigated by properly screening and vetting patients, as well as by the addition of magnesium to ibogaine treatment. Magnesium is an essential component, as it is cardioprotective. … It simply raises the threshold for an irregular heartbeat or to occur." [17:38]

"A first degree relative with schizophrenia, for example, would be a relative contraindication. However, we must think of this in terms of risk and benefit. If this person is injecting fentanyl every day, they are at risk of overdose and death every single day. … so that relative contraindication should always be ascertained in terms of risk-benefit, particularly risk to life when it is present." [29:31]

"The science currently supports that sufficient exposure over a short enough period of time can yield pretty much the same results in terms of [neuro]plasticity without incurring a psychedelic experience. And we have tailored some specific treatments for patients that did not wish to incur a psychedelic experience, yet wanted to obtain the benefits of the plastic component of ibogaine treatment." [32:15]

Links:

Dr. Rivas on Instagram

Transcend Clinic website

Previous episode: Psychedelics and Psychosis with Alexander Lebedev, MD, PhD

Psychedelic Medicine Association

Porangui

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(214)

What Happens to Relationships After Psychedelic-Assisted Therapy? with Shira Myrow, LMFT

What Happens to Relationships After Psychedelic-Assisted Therapy? with Shira Myrow, LMFT

In this episode of the Psychedelic Medicine Podcast, Shira Myrow, LMFT joins to discuss the impacts of psychedelic-assisted therapy on relationships. Shira is a couples psychotherapist with nearly two...

18 Marras 37min

Hallucinogen Persisting Perception Disorder (HPPD) with Steven Locke, MD, DLFAPA

Hallucinogen Persisting Perception Disorder (HPPD) with Steven Locke, MD, DLFAPA

In this episode of the Psychedelic Medicine Podcast, Steven Locke, MD, DLFAPA joins to discuss the intricacies of Hallucinogen Persisting Perception Disorder (HPPD). Dr. Locke is a former Associate Pr...

4 Marras 56min

Psilocybin for Phantom Limb Pain with Jon Dean, PhD

Psilocybin for Phantom Limb Pain with Jon Dean, PhD

In this episode of the Psychedelic Medicine Podcast, Jon Dean, PhD joins to discuss the potential of psilocybin therapies for phantom limb pain. Dr. Dean is an assistant professor at UC San Diego, whe...

21 Loka 36min

Psilocybin for PTSD with Stacey Armstrong, PhD

Psilocybin for PTSD with Stacey Armstrong, PhD

In this episode of the Psychedelic Medicine Podcast, Stacey Armstrong, PhD joins to discuss the latest research on psilocybin treatments for PTSD. Dr. Armstrong is Associate Director and Senior Resear...

7 Loka 37min

Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD

Extended Post-Psychedelic Difficulties with Christian Jurlando, PhD

In this episode of the Psychedelic Medicine Podcast, Christian Jurlando, PhD, joins to unpack the topic of extended difficulties following psychedelic experiences. Dr. Jurlando is a humanities profess...

23 Syys 34min

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

Why Psychedelics Don't Always Change Us with Nigel Denning, MA, MPsych

In this episode of the Psychedelic Medicine Podcast, Nigel Denning, MA, MPsych, joins to discuss the reasons profound psychedelic experiences don't always lead to lasting change. Nigel is a Counsellin...

9 Syys 35min

Encore Episode: Psychedelics and Breathwork with Kyle Buller

Encore Episode: Psychedelics and Breathwork with Kyle Buller

This encore episode of the Psychdelic Medicine Podcast features a conversation with Kyle Buller on psychedelics and breathwork. Kyle is co-founder and host of the Psychedelics Today podcast and he has...

13 Elo 43min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
tiedenaiset-podcast
psykopodiaa-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
aamukahvilla
meditaatiot-suomeksi
rss-pt-paahtio
rss-uplevel-by-sonja-hannus
voi-hyvin-meditaatiot-2
terapiassa
katilon-kahvitunti
fitnessvastaanotto
hippokrateen-vastaanotolla
rss-duodecim-lehti
junnut-pelissa
rss-adama-mindful-hetki
rss-lihavuudesta-podcast
rss-sanelunpurku-podcast
rss-pitaisko-erota
paritellen